Infinity Pharmaceuticals Aktie

Kaufen
Verkaufen
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Bei einem anderen Broker handeln Smartphone

Marktkap. 871,61 EUR

Div. Rendite 0,00%

WKN A0LA4Y

ISIN US45665G3039

Symbol INFIQ


Infinity Pharmaceuticals Aktie Analyse

27.06.19 Infinity Pharmaceuticals Outperform Oppenheimer & Co. Inc.
04.01.19 Infinity Pharmaceuticals Buy B. Riley FBR
15.06.16 Infinity Pharmaceuticals Sector Perform RBC Capital Markets
14.06.16 Infinity Pharmaceuticals Mkt Perform FBR Capital
02.03.16 Infinity Pharmaceuticals Outperform FBR Capital
25.02.16 Infinity Pharmaceuticals Neutral Wedbush Morgan Securities Inc.
07.08.15 Infinity Pharmaceuticals Outperform RBC Capital Markets
07.05.15 Infinity Pharmaceuticals Buy Deutsche Bank AG
20.10.14 Infinity Pharmaceuticals Hold Stifel, Nicolaus & Co., Inc.
17.12.12 Infinity Pharmaceuticals outperform RBC Capital Markets
26.11.12 Infinity Pharmaceuticals outperform RBC Capital Markets
21.11.12 Infinity Pharmaceuticals outperform RBC Capital Markets
08.11.12 Infinity Pharmaceuticals hold Jefferies & Company Inc.
24.08.12 Infinity Pharmaceuticals hold Stifel, Nicolaus & Co., Inc.